Ledger.Open graph →
SEC Form D · filed February 17, 2015

Pronutria Biosciences, Inc

Offering
$28.3M
Sold
$28.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Peter B. Hutt · CAMBRIDGE, MADirectorNoubar Afeyan · CAMBRIDGE, MADirectorJohn B. Mendlein · CAMBRIDGE, MADirectorDavid Berry · CAMBRIDGE, MADirectorRobert Connelly · CAMBRIDGE, MAExec · DirectorGary B. Pisano · CAMBRIDGE, MADirectorJeff B. Moore · CAMBRIDGE, MAExecGlenn B. Nedwin · CAMBRIDGE, MADirectorCharles Cooney · CAMBRIDGE, MADirectorStephen Hoge · CAMBRIDGE, MADirectorAndrew Smith · Philadelphia, PAExecJeffrey L. Cotton · Philadelphia, PADirectorChristopher Edwards · Philadelphia, PADirectorMarika Tooze · Philadelphia, PAExec · DirectorSusan Mullin · Philadelphia, PADirectorJennifer A. Nichols · Philadelphia, PADirectorRichard Fonash · Philadelphia, PAExec · DirectorAlan R. Goodson · Philadelphia, PADirectorFrank S. Ioppolo · Lake Mary, FLDirectorEugene D. James · NEW YORK, NYDirectorCharles Ayres · NEW YORK, NYDirectorElliot R. Attie · NEW YORK, NYDirectorChristopher R. Manning · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗